Apotex settlement with US states over generic drug prices gets preliminary nod
MLex Summary: Apotex’s $39.1 million settlement with US states to resolve allegations that it conspired to artificially inflate and manipulate prices regarding numerous generic prescription drugs was granted preliminary approval by...To view the full article, register now.
Already a subscriber? Click here to view full article